Sensome, formerly Instent, a company developing a revolutionary micro-sensor technology for smart medical devices out of France’s Ecole Polytechnique and CNRS, announced today that it has completed its €4.7m seed round to bring its first product to clinical trials. Venture capital firm Kurma Diagnostics led a syndicate with the new Paris-Saclay fund and ID Invest, joined by a group of business angels.
Sensome’s first application of its AI-powered micro-sensor technology can detect the composition of the blockage in the brain during stroke treatment
Sensome’s novel sensing technology can be integrated with any medical device to reliably identify biological tissues in contact with the device. The technology combines micrometric impedance sensors that communicate wirelessly outside the body and machine learning algorithms for accurate and predictive real-time analysis.
Sensome’s first product integrates its proprietary technology with a guidewire for the treatment of ischemic stroke. When a brain blood vessel is blocked by a clot, millions of brain cells die every minute. Depending on the composition of the blood clot, the choice of tool to remove the clot significantly impacts the time to reopen the artery, ranging from minutes to hours. Sensome’s connected stroke guidewire will help select the fastest device to reopen the vessel for each patient. Ischemic stroke affects over 1.5 million people across Europe and the US every year.
“This seed round allows us to prepare first-in-human testing of our neurovascular product next year and to enter the stroke space”, says Franz Bozsak, CEO of Sensome, who co-founded the company with Abdul Barakat, professor at the Hydrodynamics Laboratory at Ecole Polytechnique/CNRS. “The connected stroke guidewire will finally provide physicians with the information they need to reduce procedure times. This first smart product with Sensome inside will pave the way for future devices integrating our technology for the benefit of patients.”
ABOUT ÉCOLE POLYTECHNIQUE / École Polytechnique, also known as L’X, is the leading French institution combining top-level research, academics, and innovation at the cutting-edge of science and technology. Its various undergraduate and graduate-level programs – Bachelor of Science, Ingénieur Polytechnicien (Master’s level program), Master’s, and PhD – are highly selective and promote a culture of excellence with a strong emphasis on science, anchored in humanist traditions. As a widely internationalized university, École Polytechnique offers a variety of international programs and attracts a growing number of foreign students and researchers from around the globe (currently 36% of students and 39% of faculty members).
École Polytechnique offers an exceptional education to prepare bright men and women to excel in top-level key positions and lead complex and innovative projects which meet the challenges of 21st century society, all while maintaining a keen sense of their civil and social responsibilities. With its 22 laboratories, 21 of which are joint research units with the French National Center for Scientific Research (CNRS), the École Polytechnique Research Center explores the frontiers of interdisciplinary knowledge to provide major contributions to science, technology, and society. École Polytechnique is also a pioneer and leading institution of the major scientific and economic cluster, Paris-Saclay, bringing together top French higher education and research institutions, as well as R&D centers of prominent international companies.